Marco A. Chacón
Marco A. Chacón, Ph.D., is the Founder and Chairman of Paragon Bioservices, Inc., a contract development and GMP manufacturing organization (CDMO) located at the University of Maryland BioPark in Baltimore. Paragon specializes in the development and GMP manufacturing of viral vectors and vaccines.
He is also the Founder of IRAZU Biodiscovery, a regenerative medicine company seeking to develop therapeutic interventions to induce hypoxia tolerance and neuroprotection as described in experimental models of caloric restriction, hibernation and the neonatal period in mammals.
Dr. Chacón also serves as the Assistant Vice President of Industry Alliances at the University of Maryland, Baltimore (UMB). As a biopharmaceutical executive and entrepreneur, Dr. Chacón works with the leadership team at UMB, leading special projects to strengthen the University's research collaborations with the biopharmaceutical industry by developing university intellectual property projects.
Dr. Chacón received a B.S. degree from Youngstown State University and a Ph.D. Degree from the University of Maryland, College Park. He currently serves on the board of trustees of the University of Maryland, Baltimore (UMB) Foundation and was appointed in 2016 to the Life Sciences Advisory Board by Maryland Governor Lawrence J. Hogan, Jr.